Subclinical inflammation after laser in situ keratomileusis

J Cataract Refract Surg. 1998 Aug;24(8):1059-63. doi: 10.1016/s0886-3350(98)80098-9.

Abstract

Purpose: To determine whether laser in situ keratomileusis (LASIK) for the correction of myopia induces an anterior chamber inflammatory response measurable with laser flare-cell photometry.

Setting: Instituto Oftalmológico de Alicante, University of Alicante. Alicante, Spain.

Methods: Twenty eyes in 20 patients had LASIK to correct myopia ranging from 2.50 to 15.00 diopters (D) (mean -8.94 +/- 3.25 [SD]). Anterior chamber inflammation was measured preoperatively and 1, 3, 7, and 15 days and 1 and 3 months postoperatively using the flare mode of a laser flare-cell meter. All eyes received topical fluorometholone 0.1% drops for 2 weeks postoperatively.

Results: Anterior chamber flare values at 1 and 3 days and 1 week postoperatively were not significantly different from those found preoperatively. However, a significant decrease was found at 2 weeks and 1 month (P < .01 and P < .05, respectively). Flare values returned to their preoperative levels at 3 months. No significant correlations between postoperative flare values and depth of ablation were found.

Conclusion: In this study. LASIK did not induce an inflammatory response in the anterior chamber in the myopic eye.

MeSH terms

  • Adult
  • Anterior Chamber / pathology*
  • Corneal Stroma / surgery*
  • Female
  • Fluorophotometry
  • Humans
  • Laser Therapy / methods*
  • Male
  • Middle Aged
  • Myopia / surgery*
  • Ophthalmologic Surgical Procedures / adverse effects*
  • Prospective Studies
  • Uveitis, Anterior / etiology*
  • Uveitis, Anterior / pathology